GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (XPAR:ALEMG) » Definitions » Change In Receivables

Labo Euromedis (XPAR:ALEMG) Change In Receivables : €0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Labo Euromedis Change In Receivables?

Labo Euromedis's change in receivables for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Labo Euromedis's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Labo Euromedis's change in receivables for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Labo Euromedis's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

Labo Euromedis's Accounts Receivable for the quarter that ended in Jun. 2023 was €10.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Labo Euromedis's Days Sales Outstanding for the six months ended in Jun. 2023 was 73.96.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Labo Euromedis's liquidation value for the six months ended in Jun. 2023 was €9.16 Mil.


Labo Euromedis Change In Receivables Historical Data

The historical data trend for Labo Euromedis's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis Change In Receivables Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Labo Euromedis Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Labo Euromedis Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis  (XPAR:ALEMG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Labo Euromedis's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=10.005/24.688*91
=73.96

2. In Ben Graham's calculation of liquidation value, Labo Euromedis's accounts receivable are only considered to be worth 75% of book value:

Labo Euromedis's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=22.171-25.591+0.75 * 10.005+0.5 * 10.144
=9.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis Change In Receivables Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis (XPAR:ALEMG) Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (XPAR:ALEMG) Headlines

No Headlines